,Article,Date,Symbol,Time,Title,Url
0,"  (Corrects to show preliminary results, not official results) NEW YORK Jan 14 NEW YORK, Jan 14 (Reuters) - Intuitive Surgical Inc :  * Shares up 12 percent in premarket trading after preliminary results     (Reporting by Ryan Vlastelica)  ",2014-01-14,ISRG,"Tue Jan 14, 2014 | 8:46am EST",CORRECTED-BRIEF-Intuitive Surgical up in premarket after preliminary results,http://www.reuters.com//article/intuitivesurgical-brief-idUSWEN00C3320140114?type=companyNews
1,"   By Bill Berkrot  Intuitive Surgical Inc (ISRG.O) on Thursday said it expects to sell fewer of its high-priced da Vinci surgical robot systems in 2014 than last year and diverged from past practice by not providing a revenue forecast for the year.The company said it would issue a revenue forecast later in the year when it has a clearer view of business trends, such as da Vinci use for benign gynecology surgeries, which has been slowing in the United States, and whether it secures reimbursements for procedures in Japan in addition to prostate surgeries.Intuitive said it expects da Vinci procedure growth this year of 9 percent to 12 percent, down from 16 percent in 2013. Procedures grew by about 12 percent in the fourth quarter of 2013.Intuitive Surgical shares fell 4.5 percent to $419.33 in extended trading, from a Nasdaq close at $439. Intuitive, which had experienced double-digit revenue growth and steadily rising da Vinci sales in past years, saw those trends hit a wall in 2013 in part due to media reports questioning the cost effectiveness of using the robots for certain procedures, capital spending uncertainty by hospitals, and physicians holding off on recommending prostate surgery for slower-progressing cancers.As a result, the company missed out on the big 2013 stock rally; its shares were one of the worst performers in healthcare, falling about 21 percent for the year.The company on Thursday said its growth in general surgeries and improved business outside the United States was partially offsetting declines in U.S. prostate procedures, once the bread and butter for the company. ""For 2014, we are focused on expanding use of da Vinci in general surgery, particularly colorectal surgery and single-incision surgery, supporting worldwide gynecology and urology growth, broadening our stapling and Single-Site launches, and continuing to strengthen our capabilities in international markets, particularly Europe and Japan,"" Intuitive Chief Executive Gary Guthart said.Intuitive reported fourth-quarter profit that easily exceeded diminished Wall Street expectations, despite another steep decline in da Vinci sales. Results were helped by a lower tax rate and operating cost reduction. Net profit fell to $166 million, or $4.28 per share, from a profit of $175 million, or $4.25 per share a year ago. Analysts' on average were looking for earnings of $3.83 per share, according to Thomson Reuters I/B/E/S.Intuitive earlier this month at an investor conference pre-announced its sales results for the quarter. Da Vinci sales fell 23 percent to $205 million as the company sold 138 systems compared with 175 a year ago. It was an improvement over the third quarter, however, when 101 of the $1.5 million da Vinci systems were sold.The company, on a conference call with analysts, said it expected to sell more of its less expensive da Vinci systems in 2014, further contributing to revenue uncertainty.(Reporting by Bill Berkrot; Editing by Bernard Orr and Leslie Adler)",2014-01-23,ISRG,"Thu Jan 23, 2014 | 6:07pm EST",Intuitive Surgical sees fewer da Vinci robot sales in 2014,http://www.reuters.com//article/us-intuitive-results-idUSBREA0M23120140123?type=companyNews
2,  Jan 23 Intuitive Surgical Inc :  * Sees 2014 procedure growth 9-12 percent  * Sees fewer da Vinci system sales in 2014 than 2013  * Declines to provide 2014 revenue forecast until later in year   ,2014-01-23,ISRG,"Thu Jan 23, 2014 | 5:36pm EST",BRIEF-Intuitive Surgical sees fewer da Vinci sales,http://www.reuters.com//article/intuitivesurgical-results-idUSWEN00C9U20140123?type=companyNews
3,"  Intuitive Surgical Inc (ISRG.O) on Thursday reported fourth quarter profit that easily exceeded diminished Wall Street expectations despite another steep decline in sales of its high priced da Vinci surgical robot systems.The company said net profit fell to $166 million, or $4.28 per share, from a profit of $175 million, or $4.25 per share a year ago. But analysts' on average were looking for earnings of $3.83 per share, according to Thomson Reuters I/B/E/S. Intuitive earlier this month at an investor conference pre-announced its sales results for the quarter. Da Vinci sales fell 23 percent to $205 million as the company sold 138 systems compared with 175 a year ago. It was an improvement over the third quarter, however, when 101 of the $1.5 million da Vinci systems were sold.  (Reporting by Bill Berkrot; Editing by Bernard Orr)",2014-01-23,ISRG,"Thu Jan 23, 2014 | 4:43pm EST",Intuitive Surgical profit tops Street view despite sales decline,http://www.reuters.com//article/us-intuitive-results-idUSBREA0M1Y420140123?type=companyNews
4,"  Jan 23 Intuitive Surgical Inc on Thursday reported fourth quarter profit that easily exceeded diminished Wall Street expectations despite another steep decline in sales of its high priced da Vinci surgical robot systems.The company said net profit fell to $166 million, or $4.28 per share, from a profit of $175 million, or $4.25 per share a year ago. But analysts' on average were looking for earnings of $3.83 per share, according to Thomson Reuters I/B/E/S.  Intuitive earlier this month at an investor conference pre-announced its sales results for the quarter. Da Vinci sales fell 23 percent to $205 million as the company sold 138 systems compared with 175 a year ago. It was an improvement over the third quarter, however, when 101 of the $1.5 million da Vinci systems were sold. ",2014-01-23,ISRG,"Thu Jan 23, 2014 | 4:41pm EST",Intuitive Surgical profit tops Street view despite sales decline,http://www.reuters.com//article/intuitive-results-idUSL2N0KX2CS20140123?type=companyNews
5,  NEW YORK Jan 23 Intuitive Surgical Inc :  * Shares were up 2.2 percent after the bell following results   ,2014-01-23,ISRG,"Thu Jan 23, 2014 | 4:15pm EST",BRIEF-Intuitive Surgical shares up 2.2 pct after the bell following results,http://www.reuters.com//article/intuitivesurgical-brief-idUSWEN00C9L20140123?type=companyNews
6,"  (For more market insights, including options activity, click on  ; for the Day Ahead newsletter link.reuters.com/mex49s;  for the Morning News Call newsletter, link.reuters.com/nex49s)   U.S. stock index futures fell on Friday. Dow Jones industrial average futures were down 0.64 percent at 16,047, S&P 500 futures were down 0.69 percent at 1,811.7 and Nasdaq 100 futures were down 0.67 percent at 3,589.5.** MICROSOFT CORP, Thursday close $36.055, +3.23 pct premarketThe company posted a bigger-than-expected quarterly profit on Thursday, boosted by strong sales of its software and services for businesses, a solid holiday season for its new Xbox game console and Surface tablets, and a slightly lower tax bill.** XEROX CORP,  Thursday close $11.76, -1.96 pct premarketThe company, best known as a maker of printers and copiers, reported weaker-than-expected quarterly revenue.** EBAY INC, Thursday close $54.94, -0.89 pct premarketActivist investor Carl Icahn's stake in e-commerce company eBay is more than previously reported at close to 2 percent, a source familiar with the matter said on Thursday. EBay said this week that Icahn had taken a 0.82 percent interest in the company earlier this month and made a non-binding proposal for eBay to spin off its PayPal payments business.** GENERAL MOTORS, Thursday close $38.42, -0.83 pct premarketThe company is seeking to cut shifts by half at one of its South Korean factories as it realigns global manufacturing in a move that could affect about 1,100 jobs, a source with direct knowledge of the matter told Reuters on Friday.** STARBUCKS CORP, Thursday close $73.39, +0.69 pct premarketThe world's biggest coffee chain's quarterly sales at established restaurants in its U.S.-dominated Americas region cooled more than analysts expected as online shopping kept more consumers at home and reduced their visits to its coffee bars.However, the company boosted its fiscal 2014 earnings per share forecast to a range of $2.59 to $2.67, from $2.55 to $2.65 previously.** INTUITIVE SURGICAL INC, Thursday close $439, -6.61 pct premarketThe company said on Thursday that it expected to sell fewer of its high-priced da Vinci surgical robot systems in 2014 than last year and diverged from past practice by not providing a revenue forecast for the year.** JUNIPER NETWORKS INC, Thursday close $26.01, +5.73 pct premarketJana Partners LLC has taken a large stake in the network gear maker, a move that comes at a time when Juniper is being urged by one of its prominent investors to increase shareholder returns.** HONEYWELL INTERNATIONAL INC, Thursday close $89.8, -0.22 pct premarketThe diversified U.S. manufacturer posted a higher fourth-quarter profit after sales increased across its major segments. The company said net income rose to $947 million, or $1.19 per share, from $251 million, or 32 cents per share, a year earlier.** BRISTOL-MYERS SQUIBB CO,  Thursday close $53.95, +2.48 pct premarketThe drugmaker's quarterly sales and earnings beat Wall Street expectations, helped by cost cuts and growing sales of its treatments for cancer, blood clots and diabetes.** BOEING, Thursday close $141.31, -0.22 pct premarketThe reliability of Boeing's 787 Dreamliner is slowly improving but it is still not at a satisfactory level and the firm is working to improve the jet's performance, said Mike Fleming, Boeing's vice president for 787 support and services.** PROCTER & GAMBLE CO, Thursday close $78.24, +0.01 pct premarketThe world's largest household products maker reported lower quarterly profit on Friday, hurt by unfavorable currency movements and lower gross profit margin. ** QUALCOMM INC, Thursday close $75.87, -0.74 pct premarket** HEWLETT-PACKARD CO, Thursday close $29.37, -1.63 pct premarketChipmaker Qualcomm acquired a patent portfolio from Hewlett-Packard, including those of its iPaq smartphone, for an undisclosed amount. The portfolio comprises about 1,400 granted patents and pending patent applications from the United States and about 1,000 granted patents and pending patent applications from other countries.** CONSOL ENERGY INC Thursday close $38The company forecast first-quarter natural gas output at 47-48 billions of cubic feet equivalent (Bcfe) of gas, flat from 48.5 Bcfe it produced in the fourth quarter ended Dec. 31. It estimated first-quarter coal production at 7.2-7.6 million tons compared with 7.1 million tons produced in the fourth quarter.** MCKESSON CORP, Thursday close $172.37, +3.24 pct premarketThe U.S. drugs distributor succeeded in its second attempt to win control of German peer Celesio in a deal with Celesio's two largest shareholders, German investment group Haniel and U.S. hedge fund Elliott.** INTERNATIONAL GAME TECHNOLOGY, Thursday close $17.65, -10.76 pct premarketThe slot-machine maker warned that its full-year profit would more likely be towards the lower end of its previous forecast due to continued weakness in the North American gaming market.** JA SOLAR HOLDINGS CO LTD, Thursday close $9.31** RENESOLA LTD, Thursday close $3.78** YINGLI GREEN ENERGY HOLDING CO LTD, Thursday close $6.38** TRINA SOLAR LTD, Thursday close $15.1 U.S. trade officials opened investigations on Thursday into imports of certain solar power products from China and Taiwan, following a complaint at the end of last year by the U.S. unit of German solar manufacturer SolarWorld AG.The company at the time said it was seeking to close a loophole that enabled Chinese solar panel producers to evade U.S. import duties by using cells manufactured in other countries, mainly Taiwan.** LOCKHEED MARTIN CORP, Thursday close $150.49A new U.S. Defense Department report warned that ongoing software, maintenance and reliability problems with Lockheed Martin's F-35 stealth fighter could delay the Marine Corps' plans to start using its F-35 jets by mid-2015.The company forecast on Thursday higher earnings in 2014 after charges linked to U.S. defense budget cuts and workforce reductions depressed earnings in the fourth quarter.** BANK OF AMERICA CORP, Thursday close $16.86, -0.95 pct premarketThe lender is looking to win more advisory and stock underwriting business to offset an expected slowdown in the issuance of corporate bonds, a top executive said in an interview on Thursday.** APPLIED MICRO CIRCUITS CORP, Thursday close $11.35, -2.20 pct after marketThe chipmaker reported third-quarter revenue slightly below estimates on Thursday, prompting brokerage BMO Capital Markets to lower its price target on the company's stock to $12 from $14.** ALTERA CORP, Thursday close $32.93, +3.20 after marketThe company reported better-than-expected fourth-quarter results, helped by higher sales of its new programmable chips.** E*TRADE FINANCIAL CORP, Thursday close $21.04, +1.09 pct after marketOne year after hiring a new chief executive to help it recover from a near brush with bankruptcy, the company said it earned $57.9 million in the fourth quarter, reversing a year-earlier loss, as clients revved up trading while costs for bad loans fell. ** DISCOVER FINANCIAL SERVICES, Thursday close $52.4, +2.00 after marketThe credit card issuer reported a better-than-expected 11 percent rise in quarterly profit as more consumers used cards to make payments.** OPEN TEXT CORP, Thursday close $90.62, +5.30 pct after marketThe Canadian business software maker's  second-quarter results beat analysts' estimates, driven by higher license sales and customer service revenue.** PROGENICS PHARMACEUTICALS INC, Thursday close $6.73, -2.67 pct after marketThe company filed a prospectus, called a shelf registration, with the U.S. Securities and Exchange Commission seeking to raise up to $150 million through the potential sale of securities that could include stock, debt securities, or warrants.** MAXIM INTEGRATED PRODUCTS INC, Thursday close $28.88, -5.00 pct after marketThe chipmaker reported lower-than-expected second-quarter profit on Thursday as operating expenses rose 15 percent. The company also forecast current-quarter results largely below analysts' expectations.** KKR & CO, Thursday close $25.77** BLACKROCK INC, Thursday close $315.57KKR & Co and BlackRock are among the investors in talks to buy a stake in China Huarong Asset Management Co Ltd as the bad debt manager seeks to raise more than $2 billion, people familiar with the matter told Reuters.** NOVARTIS, Thursday close $81.79, -0.71 pct premarketThe company still sees heart failure drug serelaxin as a potential blockbuster, even after backing down from original launch plans when the European health regulator dealt the drug a blow.** AMGEN INC, Thursday close $123.6A cholesterol fighter developed by Amgen from a highly promising new class of medicines significantly lowered levels of ""bad"" LDL cholesterol in a late stage trial in patients unable to tolerate statin drugs, the company said on Thursday.** GOLDMAN SACHS GROUP INC, Thursday close $170.75The bank may stop traders from using certain chat messaging services to protect internal conversations that are lately being subjected to intense regulatory scrutiny, the Wall Street Journal reported.** HESS CORP, Thursday close $77.4The oil and gas producer said on Thursday that it would spend $5.8 billion on exploration and production this year, a 15 percent drop from 2013 as it focuses more on greater efficiency in its U.S. shale fields.** SYNGENTA AG, Thursday close $77.81Two leading U.S. grain groups have asked the world's largest crop chemicals company to suspend the commercial use in the United States of two genetically modified strains of corn not currently approved in China.** RAYTHEON CO, Thursday close $91.1The U.S. arms maker announced on Thursday that it received a $1.28 billion order from Oman for an advanced surface-to-air missile system. The company said the contract was awarded in the fourth quarter of 2013 and included ground support equipment, training support and technical assistance.    (Compiled by Neha Dimri in Bangalore; Editing by Kirti Pandey)",2014-01-24,ISRG,"Fri Jan 24, 2014 | 7:39am EST","MARKET PULSE-Microsoft, Xerox, Intuitive Surgical, Qualcomm, GM",http://www.reuters.com//article/markets-usa-stocks-pulse-idUSL3N0KY3CB20140124?type=companyNews
7,"  April 1 Intuitive Surgical Inc said the U.S. Food and Drug Administration approved for marketing an upgraded version of its flagship robotic surgical system, sending the company's shares up as much as 15 percent.The company said it launched the device, da Vinci Xi Surgical System, in the United States on Tuesday.The device enables surgeons to perform complex procedures using a minimally invasive approach.""The new system came a bit earlier than we expected, is a very good improvement on the open surgery part of the ledger -particularly for colorectal surgery,"" Suntrust Robinson Humphrey analyst Amit Hasan wrote in a note.Hasan said it also opens up further technology upgrades that were not possible on the older system. Intuitive Surgical launched its last major upgrade of the da Vinci system in 2009.The company, which experienced strong revenue growth on steadily rising sales of da Vinci systems in past years, saw demand slow last year amid concerns regarding cost effectiveness of the device and insurer resistance to reimburse some procedures. The da Vinci system witnessed a steep 23 percent decline in sales to $205 million in the fourth quarter of 2013.""... if history is any guide, the new system might as well trigger increased demand and a product upgrade cycle, despite ongoing hospital budget constraints,"" Stifel Nicolaus analysts said in a note. The Sunnyvale, California-based company's stock was up about 8 percent at $473.82 in late morning trade on the Nasdaq.(Reporting by Natalie Grover in Bangalore; Editing by Sriraj Kalluvila)",2014-04-01,ISRG,"Tue Apr 1, 2014 | 11:54am EDT",FDA clears new version of Intuitive's da Vinci surgical robot,http://www.reuters.com//article/intuitivesurgical-fda-davincisystem-idUSL4N0MT3PX20140401?type=companyNews
8,"  Intuitive Surgical Inc (ISRG.O) estimated first-quarter revenue well below analysts' average expectation mainly due to a steep 60 percent drop in sales of its flagship da Vinci robot system.The company's shares fell nearly 10 percent in extended trading.Intuitive Surgical said it expects revenue of $465 million for the quarter. Analysts on average were expecting sales of $537.9 million, according to Thomson Reuters I/B/E/S.The medical device maker reported revenue of $611 million a year earlier.Revenue from da Vinci Surgical Systems fell nearly 59 percent to about $106 million in the first quarter of 2014, Intuitive said on Tuesday. The device maker sold 87 systems in the quarter, compared to 164 a year earlier. U.S. sales fell to 45 from 115.The company cited lower procedural volumes, the implementation of the Affordable Care Act and expectations of a new version of the robot system for lower U.S. shipments. Intuitive Surgical launched an upgraded version of the device, da Vinci Xi Surgical System, on April 1. ID:nL4N0MT3PX]The company said the revenue estimate included a $26 million deferral related to trade-in of da Vinci 'Si' systems for the upgraded version. Intuitive Surgical said it would also record a $67 million pre-tax charge to reflect estimated costs of settling a number of claims related to its surgical robot system.The company's shares closed at $489.84 on the Nasdaq.(Reporting by Natalie Grover in Bangalore; Editing by Sriraj Kalluvila)",2014-04-08,ISRG,"Tue Apr 8, 2014 | 6:28pm EDT",Intuitive Surgical expects revenue below estimates as da Vinci sales fall,http://www.reuters.com//article/us-intuitivesurgical-results-preliminary-idUSBREA3727K20140408?type=companyNews
9,"  * Alcoa higher after earnings* Fed minutes on tap at 2 p.m. ET* Intuitive Surgical slumps after outlook* Indexes up: Dow 0.29 pct, S&P 0.26 pct, Nasdaq 0.64 pct   (Updates to open; adds quote, data)By Chuck MikolajczakNEW YORK, April 9 U.S. stocks edged higher on Wednesday, putting the S&P 500 on track for a second straight advance, in the wake of earnings from Alcoa and ahead of the minutes from the last Federal Reserve meeting.Alcoa Inc gained 4.5 percent to $13.09 as the best performer on the S&P 500 after it reported a decline in first quarter adjusted profit, but earnings came in ahead of analysts' expectations. U.S. stocks had advanced in the prior session to snap a three-day losing streak as investors bought beaten-down social media and Internet shares.Despite the three-day selloff, the benchmark S&P 500 index  managed to hold above its 50-day moving average around 1,840, a key support level. The index has successfully defended the 1,840 area several times over the past month.""These kind of consolidation rallies really take time to shake out the emotion that goes with both sides,"" said Rick Meckler, president of investment firm LibertyView Capital Management in Jersey City, New Jersey. ""Earnings will really help give this market some forward direction but they are in front of us and haven't really hit yet."" S&P 500 companies' first-quarter earnings are projected to have increased just 1 percent from a year ago, Thomson Reuters data showed. The forecast is down sharply from the start of the year, when profit growth was estimated at 6.5 percent.The Fed is expected to release the minutes from its March 18-19 meeting at 2 p.m. (1800 GMT). The Fed needs to be more specific about what economic conditions would prompt it to raise interest rates from current rock-bottom levels, a pair of top Fed officials normally at odds on policy said on Tuesday.Earnings season gets under way this week, with results due from retailer Bed, Bath & Beyond after the close, while financials JPMorgan Chase & Co and Wells Fargo & Co  close out the week with results on Friday. Investors will be looking at the impact of harsh winter weather on first-quarter earnings, and signs of optimism for the second-quarter.The Dow Jones industrial average rose 46.53 points or 0.29 percent, to 16,302.67, the S&P 500 gained 4.82 points or 0.26 percent, to 1,856.78 and the Nasdaq Composite  added 26.234 points or 0.64 percent, to 4,139.221.U.S. wholesale inventories rose at a slower 0.5 percent pace in February, in line with expectations, after a revised 0.8 percent gain in January, which could support views that restocking will not help the economy in the first quarter.General Motors Co shares lost 1.8 percent to $33.90. The National Highway Traffic Safety Administration said the automaker is being fined $7,000 a day for missing an April 3 deadline to provide information about its recall of 2.6 million cars for defective ignition switches. Morgan Stanley subsequently cut the stock to an ""underweight"" rating.Intuitive Surgical Inc estimated first-quarter revenue well below analysts' average expectation, mainly due to a 60 percent drop in sales of its flagship da Vinci robot system. Its shares slumped 7.3 percent to $454.04. The PHLX medical device index lost 0.9 percent.Constant Contact Inc surged 27.8 percent to $28.02 after the online marketer said it expects quarterly revenue to rise by more than 15 percent.    (Reporting by Chuck Mikolajczak; Editing by Nick Zieminski)",2014-04-09,ISRG,"Wed Apr 9, 2014 | 10:35am EDT",US STOCKS-Wall St edges up after Alcoa results; Fed minutes due,http://www.reuters.com//article/markets-usa-stocks-idUSL2N0N10SF20140409?type=companyNews
10,"  * Alcoa higher in premarket after earnings* Fed minutes on tap at 2pm ET* Intuitive Surgical slumps after outlook* Futures up: Dow 53 pts, S&P 4.5 pts, Nasdaq 12.5 ptsBy Chuck MikolajczakNEW YORK, April 9 U.S. stocks were set for a modestly higher open on Wednesday, putting the S&P 500 on track for a second straight advance, in the wake of earnings from Alcoa and ahead of the minutes from the last Federal Reserve meeting.* Alcoa Inc gained 4.2 percent to $13.06 in premarket trade after the former Dow component reported a decline in first quarter adjusted profit on Tuesday as aluminum prices dropped, but earnings came in ahead of analysts' expectations. * S&P 500 companies' first-quarter earnings are projected to have increased just 1 percent from a year ago, Thomson Reuters data showed. The forecast is down sharply from the start of the year, when profit growth was estimated at 6.5 percent.* The Federal Reserve is expected to release the minutes from its March 18-19 meeting at 2 p.m. (1800 GMT). The Fed needs to be more specific about what economic conditions would prompt it to raise interest rates from current rock-bottom levels, a pair of top Fed officials normally at odds on policy said on Tuesday.* Earnings season gets under way this week, with results due from retailer Bed, Bath & Beyond after the close, while financials JPMorgan Chase & Co and Wells Fargo & Co  close out the week with results on Friday. * Investors will be looking at the impact of harsh winter weather on first-quarter earnings, and signs of optimism for the second-quarter.* U.S. stocks advanced in the prior session to snap a three-day losing streak as investors bought beaten-down social media and Internet shares.* The benchmark S&P 500 index managed to hold above its 50-day moving average around 1,840, a key support level. The index has been able to successfully defend the 1,840 area several times over the past month. * S&P 500 e-mini futures rose 4.5 points and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures gained 53 points and Nasdaq 100 futures added 12.5 points.* General Motors Co shares lost 1.8 percent to $33.90 before the opening bell. The National Highway Traffic Safety Administration said the automaker is being fined $7,000 a day for missing an April 3 deadline to provide information about its recall of 2.6 million cars for defective ignition switches. Morgan Stanley subsequently cut the stock to ""underweight.""* Intuitive Surgical Inc estimated first-quarter revenue well below analysts' average expectation, mainly due to a 60 percent drop in sales of its flagship da Vinci robot system. Its shares slumped 9.2 percent to $444.95 in premarket trade.* Constant Contact Inc jumped 15.2 percent to $25.25 before the opening bell after the online marketer said it expects quarterly revenue to rise by more than 15 percent.     (Reporting by Chuck Mikolajczak; Editing by Nick Zieminski)",2014-04-09,ISRG,"Wed Apr 9, 2014 | 8:44am EDT",US STOCKS-Wall St to open modestly higher after Alcoa results,http://www.reuters.com//article/markets-usa-stocks-idUSL2N0N10NO20140409?type=companyNews
11,"  * Alcoa up after earnings* Fed minutes on tap* Intuitive Surgical forecasts revenue below expectations* Futures up: Dow 22 pts, S&P 0.5 pt, Nasdaq 5.5 ptsBy Chuck MikolajczakNEW YORK, April 9 U.S. stock index futures were flat on Wednesday, after the S&P 500 managed to halt a three-day losing skid, in the wake of earnings from Alcoa and ahead of the minutes from the last Federal Reserve meeting. * Alcoa Inc gained 2.6 percent to $12.86 in premarket trade after the former Dow component reported a decline in first quarter adjusted profit on Tuesday as aluminum prices dropped, but earnings came in ahead of analysts' expectations.* S&P 500 companies' first-quarter earnings are projected to have increased just 1 percent from a year ago, Thomson Reuters data showed. The forecast is down sharply from the start of the year, when profit growth was estimated at 6.5 percent.* The Federal Reserve is expected to release the minutes from its March 18-19 meeting. The Fed needs to be more specific about what economic conditions would prompt it to raise interest rates from current rock-bottom levels, a pair of top Fed officials normally at odds on policy said on Tuesday. * Earnings season gets under way this week, with results due from companies including retailer Bed, Bath & Beyond  after the close, while financials JPMorgan Chase & Co  and Wells Fargo & Co close out the week with results on Friday.* U.S. stocks advanced in the prior session to snap a three-day losing streak as investors bought beaten-down social media and Internet shares.* The benchmark S&P 500 index managed to hold above its 50-day moving average around 1,840, a key support level. The index has been able to successfully defend 1,840 several times over the past month. * S&P 500 e-mini futures rose 0.5 point and were about even with fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures  gained 22 points and Nasdaq 100 futures added 5.5 points.* General Motors Co shares lost 2.4 percent to $33.69 before the opening bell. The National Highway Traffic Safety Administration said the automaker is being fined $7,000 a day for missing an April 3 deadline to provide information about its recall of 2.6 million cars for defective ignition switches. Morgan Stanley cut the stock to ""underweight.""* Intuitive Surgical Inc estimated first-quarter revenue well below analysts' average expectation, mainly due to a 60 percent drop in sales of its flagship da Vinci robot system. Its shares slumped 11.4 percent to $434 in light premarket trade.* European shares rebounded, led by automakers, although caution ahead of the European earnings season could keep gains in check.* Asian shares rose after Wall Street reversed a three-day losing streak, but Japanese stocks dropped sharply after the yen surged on fading hopes of near-term stimulus from the Bank of Japan.    (Reporting by Chuck Mikolajczak; Editing by Nick Zieminski)",2014-04-09,ISRG,"Wed Apr 9, 2014 | 7:32am EDT",US STOCKS-Futures flat after Alcoa results; Fed minutes on tap,http://www.reuters.com//article/markets-usa-stocks-idUSL2N0N10HX20140409?type=companyNews
12,"   By Natalie Grover  Intuitive Surgical Inc (ISRG.O) estimated first-quarter revenue well below analysts' average expectation mainly due to a 60 percent drop in sales of its flagship da Vinci robot system.The company's shares fell nearly 10 percent in extended trading.It is unclear how the company plans to resuscitate the growth it experienced when the surgical robot system was first launched, Northland Capital Markets analyst Suraj Kalia told Reuters, considering its under-utilization in hospitals where it is currently present.""Based on our assessment, there exists at least a 40 to 50 percent unused capacity in Da Vinci systems installed the United States; and even higher outside the U.S.,"" he said, saying the freshest version on the market would serve to only stratify an already saturated market.However, other analysts believe that while underutilization exists the upgraded version of Intuitive's surgical system, launched on April 1, could revive its fortunes by opening up other markets.""Going forward growth is to come from new markets like general surgery,"" Jefferies & Co analyst Imron Zafar told Reuters, but the decline in U.S. gynecology procedures, which comprise nearly half of all procedures using the robot, has clearly affected sales negatively. Intuitive, which had experienced double-digit revenue growth and steadily rising da Vinci sales in past years, saw those trends hit a wall in 2013 in part due to media reports questioning the cost effectiveness of using the robots for certain procedures, capital spending uncertainty by hospitals, and physicians holding off on recommending prostate surgery for slower-progressing cancers.In the fourth quarter of 2013, systems sales witnessed a 23 percent decline to $205 million.Intuitive Surgical said it expects revenue of $465 million for the first quarter. Analysts on average were expecting sales of $537.9 million, according to Thomson Reuters I/B/E/S. The medical device maker reported revenue of $611 million a year earlier.Revenue from da Vinci Surgical Systems fell nearly 59 percent to about $106 million in the first quarter of 2014, Intuitive said on Tuesday.The device maker sold 87 systems in the quarter, compared to 164 a year earlier. U.S. sales fell to 45 from 115. The company cited lower procedural volumes, the implementation of the Affordable Care Act and expectations of a new version of the robot system for lower U.S. shipments.The company said the revenue estimate included a $26 million deferral related to trade-in of da Vinci 'Si' systems for the upgraded version.Intuitive Surgical said it would also record a $67 million pre-tax charge to reflect estimated costs of settling a number of claims related to its surgical robot system.The company's shares closed at $489.84 on the Nasdaq.(Reporting by Natalie Grover in Bangalore; Editing by Sriraj Kalluvila and Cynthia Osterman)",2014-04-09,ISRG,"Tue Apr 8, 2014 | 8:02pm EDT",Intuitive Surgical expects revenue below estimates as da Vinci sales fall,http://www.reuters.com//article/us-intuitivesurgical-results-preliminary-idUSBREA3727K20140409?type=companyNews
13,"  Intuitive Surgical Inc (ISRG.O) on Tuesday lowered its forecast for procedure growth for its da Vinci surgical robots, citing a slowdown in U.S. gynecology procedures.The medical device maker said it now expects da Vinci procedure growth in a range of 2 percent to 8 percent, down from the prior forecast of 9 percent to 12 percent.The lower, wider range reflects uncertainty about the impact on procedure volumes as hospitals adjust to the implications of the Affordable Care Act, company officials said on a conference call after the release of first-quarter earnings.Intuitive said revenue in the first quarter fell about 24 percent from a year ago to $465 million, consistent with the estimate it provided earlier this month. First-quarter net income, including a $67 million charge for settling legal claims related to its surgical robotic system, was $44 million, or $1.13 a share, compared with $189 million, or $4.56 a share, in the same period a year ago. The company also cited customers' anticipation of a new version of the robot system for lower U.S. shipments.Intuitive saw double-digit revenue growth and steadily rising da Vinci sales in past years, but sales fell for the first time in 2013 as cost and safety concerns hurt demand. Intuitive launched an upgraded version of its surgical system on April 1, which some analysts believe will revive sales.(Reporting by Susan Kelly in Chicago; Editing by Lisa Shumaker)",2014-04-22,ISRG,"Tue Apr 22, 2014 | 6:10pm EDT",Intuitive Surgical cuts outlook for growth in robot procedures,http://www.reuters.com//article/us-intuitive-outlook-idUSBREA3L1TE20140422?type=companyNews
14,"  April 22 Intuitive Surgical Inc on Tuesday lowered its forecast for procedure growth for its da Vinci surgical robots, citing a slowdown in U.S. gynecology procedures.The medical device maker said it now expects da Vinci procedure growth in a range of 2 percent to 8 percent, down from the prior forecast of 9 percent to 12 percent.The lower, wider range reflects uncertainty about the impact on procedure volumes as hospitals adjust to the implications of the Affordable Care Act, company officials said on a conference call after the release of first-quarter earnings. Intuitive said revenue in the first quarter fell about 24 percent from a year ago to $465 million, consistent with the estimate it provided earlier this month.First-quarter net income, including a $67 million charge for settling legal claims related to its surgical robotic system, was $44 million, or $1.13 a share, compared with $189 million, or $4.56 a share, in the same period a year ago. The company also cited customers' anticipation of a new version of the robot system for lower U.S. shipments. Intuitive saw double-digit revenue growth and steadily rising da Vinci sales in past years, but sales fell for the first time in 2013 as cost and safety concerns hurt demand.Intuitive launched an upgraded version of its surgical system on April 1, which some analysts believe will revive sales.       (Reporting by Susan Kelly in Chicago; Editing by Lisa Shumaker)",2014-04-22,ISRG,"Tue Apr 22, 2014 | 6:08pm EDT",Intuitive Surgical cuts outlook for growth in robot procedures,http://www.reuters.com//article/intuitive-outlook-idUSL2N0ND1BM20140422?type=companyNews
15,"  CHICAGO, April 22 Intuitive Surgical Inc :  * Says now sees 2014 da vinci procedure growth of 2 percent to 8 percent  * Intuitive's 2014 da vinci procedure growth forecast is below prior outlook of 9 percent to 12 percent  ",2014-04-22,ISRG,"Tue Apr 22, 2014 | 5:13pm EDT",BRIEF-Intuitive Surgical lowers 2014 da Vinci procedure growth forecast,http://www.reuters.com//article/intuitivesurgical-brief-idUSWEN00CYT20140422?type=companyNews
16,"  Intuitive Surgical Inc on Tuesday said it sold more of its high-priced robot surgical systems in the second quarter than in its dismal first quarter even as the once fast-growing company posted its fifth straight quarterly earnings decline.Sales of its da Vinci robot surgical systems, which go for about $1.5 million each, fell from a year ago but were up from the prior quarter.The company sold 96 da Vinci systems in the quarter, down from 143 a year ago but an improvement over the 87 shipped in the first quarter.Intuitive posted a net profit of $104 million, or $2.77 per share, down from $159.1 million, or $3.90 per share, a year ago.Revenue for the quarter fell 11 percent to $512.2 million but exceeded Wall Street's diminished expectations of $501.7 million, according to Thomson Reuters I/B/E/S. Instruments and accessories revenue fell about 1 percent to $262 million, but procedures using da Vinci systems rose about 9 percent, driven by growth in U.S. general surgery and international urologic procedures. Revenue per procedure was about $1,800 for Intuitive.Based on the better second quarter, the company took up the low end of its full-year procedure forecast and now sees growth of 5 percent to 8 percent. Its prior view was for growth of 2 to 8 percent. The company declined to provide a full-year revenue forecast as had been its past practice each quarter, citing numerous uncertainties. Intuitive's volatile shares rose nearly 11 percent to $435 in after hours trading. They have been about flat for the year, but are down more than 20 percent since early July of 2013.  Sunnyvale, California-based Intuitive had enjoyed double-digit revenue growth and steadily rising da Vinci sales in past years. Those trends reversed last year as media reports questioned the cost effectiveness of using the robots for certain procedures. Also contributing to the reversal: uncertainty about capital spending at hospitals, physicians holding off on recommending prostate surgery for slower-progressing cancers and a decline in benign gynecological procedures.Intuitive Chief Executive Gary Guthart said on a conference call that he was encouraged by several trends relative to the first quarter, but added that he expects constraints on hospital capital spending to continue. (Reporting by Bill Berkrot; Editing by Jonathan Oatis and David Gregorio)",2014-07-22,ISRG,"Tue Jul 22, 2014 | 6:01pm EDT",Intuitive Surgical shows improvement despite profit decline,http://www.reuters.com//article/us-intuitive-results-idUSKBN0FR2D020140722?type=companyNews
17,  July 22 Intuitive Surgical Inc :  * Sees 2014 procedure growth of 5-8 percent versus its prior view of growth of2-8 percent  * Says will not provide full year revenue forecast due to numerous  uncertainties ,2014-07-22,ISRG,"Tue Jul 22, 2014 | 5:31pm EDT",BRIEF-Intuitive Surgical adjusts procedure growth forecast,http://www.reuters.com//article/intuitivesurgical-results-idUSWEN00DN420140722?type=companyNews
18,"  (Adds sales details, share move, company comment)July 22 Intuitive Surgical Inc on Tuesday said it sold more of its high-priced robot surgical systems in the second quarter than in its dismal first quarter even as the once fast-growing company posted its fifth straight quarterly earnings decline.Sales of its da Vinci robot surgical systems, which go for about $1.5 million each, fell from a year ago but were up from the prior quarter.The company sold 96 da Vinci systems in the quarter, down from 143 a year ago but an improvement over the 87 shipped in the first quarter.Intuitive posted a net profit of $104 million, or $2.77 per share, down from $159.1 million, or $3.90 per share, a year ago. Revenue for the quarter fell 11 percent to $512.2 million but exceeded Wall Street's diminished expectations of $501.7 million, according to Thomson Reuters I/B/E/S.Instruments and accessories revenue fell about 1 percent to $262 million, but procedures using da Vinci systems rose about 9 percent, driven by growth in U.S. general surgery and international urologic procedures. Revenue per procedure was about $1,800 for Intuitive. Based on the better second quarter, the company took up the low end of its full-year procedure forecast and now sees growth of 5 percent to 8 percent. Its prior view was for growth of 2 to 8 percent.The company declined to provide a full-year revenue forecast as had been its past practice each quarter, citing numerous uncertainties. Intuitive's volatile shares rose nearly 11 percent to $435 in after hours trading. They have been about flat for the year, but are down more than 20 percent since early July of 2013.Sunnyvale, California-based Intuitive had enjoyed double-digit revenue growth and steadily rising da Vinci sales in past years. Those trends reversed last year as media reports questioned the cost effectiveness of using the robots for certain procedures. Also contributing to the reversal: uncertainty about capital spending at hospitals, physicians holding off on recommending prostate surgery for slower-progressing cancers and a decline in benign gynecological procedures.Intuitive Chief Executive Gary Guthart said on a conference call that he was encouraged by several trends relative to the first quarter, but added that he expects constraints on hospital capital spending to continue.   (Reporting by Bill Berkrot; Editing by Jonathan Oatis and David Gregorio)",2014-07-22,ISRG,"Tue Jul 22, 2014 | 5:28pm EDT",UPDATE 1-Intuitive Surgical shows improvement despite profit decline,http://www.reuters.com//article/intuitive-results-idUSL2N0PX2C120140722?type=companyNews
19,"  July 22 Intuitive Surgical Inc on Tuesday reported lower second-quarter profit as sales of its high-priced da Vinci robot surgical systems fell, marking the fifth consecutive quarter of earnings declines for the formerly fast-growing company.Intuitive posted a net profit of $104 million, or $2.77 per share, compared with a profit of $159.1 million, $3.90 per share, a year ago.Revenue for the quarter fell 11 percent to $512.2 million but exceeded Wall Street's diminished expectations of $501.7 million, according to Thomson Reuters I/B/E/S. The company sold 96 da Vinci systems in the quarter, down from 143 a year ago but an improvement over the 87 shipped in the first quarter as Intuitive showed signs of bouncing back from a dismal first three months. Sunnyvale, California-based Intuitive had enjoyed double-digit revenue growth and steadily rising da Vinci sales in past years. But those trends reversed last year as media reports questioned the cost effectiveness of using the robots for certain procedures. Also contributing to the reversal: uncertainty about capital spending at hospitals, and physicians holding off on recommending prostate surgery for slower-progressing cancers.   (Reporting by Bill Berkrot; Editing by Jonathan Oatis)",2014-07-22,ISRG,"Tue Jul 22, 2014 | 4:29pm EDT",Intuitive Surgical quarterly profit declines again,http://www.reuters.com//article/intuitive-results-idUSL2N0PW25320140722?type=companyNews
20,"  Intuitive Surgical Inc (ISRG.O) on Tuesday showed signs of bouncing back from a difficult first half of the year as sales of its da Vinci robotic surgical systems increased in the third quarter, as did procedures using the company's high-priced machines.The company posted better-than-expected adjusted profit, though net earnings fell for a sixth consecutive quarter, and it raised its forecast for 2014 procedure growth.Intuitive's products are used in gynecological and urological surgeries, among others, and the company gets significant revenue from each procedure using the da Vinci systems.Intuitive reported sales of 111 da Vinci systems, which cost about $1.5 million each, up from 96 in the second quarter and 101 in the year-ago quarter.Instrument and accessory revenue rose by about 14 percent to $273 million, driven by a 10 percent increase in procedures using da Vinci systems. As a result, the company said it now expects full-year procedure growth of 8 percent to 9 percent, up from its prior projection of 5-8 percent growth.For the second consecutive quarter, the company declined to provide a full-year revenue forecast, as had been its past practice each quarter.The company, on a conference call with analysts and investors, said business in Europe improved in the quarter, particularly in Germany. It also noted improvements in South Korea and other parts of Asia.   Intuitive posted third-quarter net profit of $123.7 million, or $3.35 per share, compared with profit of $157 million, or $3.99 per share, a year ago, marking a sixth consecutive quarter of declining profit for the formerly fast-growing company.Excluding one-time items, Intuitive earned $3.92 per share, topping analysts' average expectations by 12 cents, according to Thomson Reuters I/B/E/S. Revenue of $550 million for the quarter was up 10 percent, easily topping Wall Street's tempered expectations of $517.8 million.Intuitive Surgical shares were about flat in after-hours trading, giving back earlier extended trading gains of about 2.6 percent. The stock ended up 2.2 percent at $495.77 in Tuesday trading on the Nasdaq.   (Reporting by Bill Berkrot; editing by Chris Reese and Leslie Adler)",2014-10-21,ISRG,"Tue Oct 21, 2014 | 6:16pm EDT",Intuitive Surgical third-quarter sales top Wall St. estimates,http://www.reuters.com//article/us-intuitivesurgical-results-idUSKCN0IA2H720141021?type=companyNews
21,"  (Adds forecast, updates shares)Oct 21 Intuitive Surgical Inc on Tuesday showed signs of bouncing back from a difficult first half of the year as sales of its da Vinci robotic surgical systems increased in the third quarter, as did procedures using the company's high-priced machines.The company posted better-than-expected adjusted profit, though net earnings fell for a sixth consecutive quarter, and it raised its forecast for 2014 procedure growth.Intuitive's products are used in gynecological and urological surgeries, among others, and the company gets significant revenue from each procedure using the da Vinci systems.Intuitive reported sales of 111 da Vinci systems, which cost about $1.5 million each, up from 96 in the second quarter and 101 in the year-ago quarter. Instrument and accessory revenue rose by about 14 percent to $273 million, driven by a 10 percent increase in procedures using da Vinci systems.As a result, the company said it now expects full-year procedure growth of 8 percent to 9 percent, up from its prior projection of 5-8 percent growth. For the second consecutive quarter, the company declined to provide a full-year revenue forecast, as had been its past practice each quarter.The company, on a conference call with analysts and investors, said business in Europe improved in the quarter, particularly in Germany. It also noted improvements in South Korea and other parts of Asia. Intuitive posted third-quarter net profit of $123.7 million, or $3.35 per share, compared with profit of $157 million, or $3.99 per share, a year ago, marking a sixth consecutive quarter of declining profit for the formerly fast-growing company.Excluding one-time items, Intuitive earned $3.92 per share, topping analysts' average expectations by 12 cents, according to Thomson Reuters I/B/E/S.Revenue of $550 million for the quarter was up 10 percent, easily topping Wall Street's tempered expectations of $517.8 million.Intuitive Surgical shares were about flat in after-hours trading, giving back earlier extended trading gains of about 2.6 percent. The stock ended up 2.2 percent at $495.77 in Tuesday trading on the Nasdaq.     (Reporting by Bill Berkrot; editing by Chris Reese and Leslie Adler)",2014-10-21,ISRG,"Tue Oct 21, 2014 | 6:14pm EDT",UPDATE 2-Intuitive Surgical 3rd-quarter sales top Wall St estimates,http://www.reuters.com//article/intuitivesurgical-results-idUSL2N0SG2ON20141021?type=companyNews
22,"  Oct 21 Intuitive Surgical Inc :  * Sees 2014 procedure growth of 8-9 percent, up from prior view of 5-8 percent growth  * Declines to provide 2014 revenue forecast  ",2014-10-21,ISRG,"Tue Oct 21, 2014 | 5:28pm EDT",BRIEF-Intuitive Surgical raises procedure growth forecast,http://www.reuters.com//article/intuitivesurgical-results-idUSWEN00E4D20141021?type=companyNews
23,"  Oct 21 Intuitive Surgical Inc on Tuesday showed signs of bouncing back from a difficult first half of the year as sales of its da Vinci robotic surgical systems and procedures using the high priced machines increased in the third quarter.The company sold 111 da Vinci systems, which cost about $1.5 million each, up from 96 in the second quarter and 101 in the year-ago quarter. However net profit fell for the sixth consecutive quarter for the former fast-growth company. Intuitive posted net third quarter profit of $123.7 million, or $3.35 per share, compared with a profit of $157 million, or $3.99 per share, a year ago. Revenue of $550 million was up 10 percent, easily topping Wall Street's tempered expectations of $517.8 million.     (Reporting by Bill Berkrot; Editing by Chris Reese)",2014-10-21,ISRG,"Tue Oct 21, 2014 | 4:29pm EDT",Intuitive Surgical 3rd quarter sales top Wall St estimates,http://www.reuters.com//article/intuitivesurgical-results-idUSL2N0SG2MY20141021?type=companyNews
24,"  April 23 Intuitive Aerial publ AB :* Signs agreement with Totsu International Co., Ltd on distribution of Intuitive Aerial's cinema drone AERIGON  Source text for Eikon:  Further company coverage:    (Gdynia Newsroom) ",2015-04-23,ISRG,"Thu Apr 23, 2015 | 6:16am EDT",BRIEF-Intuitive Aerial signs distribution agreement with Totsu International,http://www.reuters.com//article/idUSFWN0XK04B20150423?type=companyNews
25,"  Robotic surgical equipment maker Intuitive Surgical Inc (ISRG.O) reported a better-than-expected quarterly profit and forecast surgical procedures to grow 11 to 13 percent this year, sending its shares up 13 percent.Procedures that used Intuitive's flagship da Vinci system, which assists in minimally invasive gynecological and urological surgeries, rose 14 percent in the second quarter from a year earlier, the company said on Tuesday.Intuitive sold 118 da Vinci systems in the quarter, up from 96 a year earlier.The United States and Japan accounted for most of the growth in system sales, Chief Executive Gary Guthart said.Surgical procedures using the company's systems increased about 10 percent in the United States and 27 percent elsewhere, company executives said on a media call. Intuitive also earns each time one of its systems is used in surgery. Guthart also said the company's gross margins were moving in the right direction as it cut product costs.Intuitive's pro forma gross margins rose to 68 percent in the second quarter from 65.6 percent in the first quarter.Revenue from the company's instrument and accessory business, its largest, rose about 13 percent to $297 million. Net income rose to $134.5 million, or $3.56 per share, in the second quarter ended June 30, from $104 million, or $2.77 per share, a year earlier.On an adjusted basis, Intuitive earned $4.57 per share, well above the average analyst estimate of $3.98, according to Thomson Reuters I/B/E/S. Revenue rose 14 percent to $586 million, beating the average estimate of $566.9 million.Up to Tuesday's close of $505.09, Intuitive's shares had fallen about 4.5 percent this year. The stock was up nearly 12 percent at $565 in after-market trading. (Reporting by Anjali Rao Koppala and Amrutha Penumudi in Bengaluru; Editing by Maju Samuel)",2015-07-21,ISRG,"Tue Jul 21, 2015 | 6:21pm EDT","Intuitive Surgical serves up strong quarter, shares jump 13 percent",http://www.reuters.com//article/us-intuitive-results-idUSKCN0PV2BL20150721?type=companyNews
26,"  * Forecasts surgical procedures to grow 11-13 pct in 2015* Posts 2nd-qtr adj profit of $4.57/shr vs est $3.98* 2nd-qtr revenue of $586 mln beats est of $566.9 mln   (Adds forecast, details from conference call; updates shares)July 21 Robotic surgical equipment maker Intuitive Surgical Inc reported a better-than-expected quarterly profit and forecast surgical procedures to grow 11 to 13 percent this year, sending its shares up 13 percent.Procedures that used Intuitive's flagship da Vinci system, which assists in minimally invasive gynecological and urological surgeries, rose 14 percent in the second quarter from a year earlier, the company said on Tuesday.Intuitive sold 118 da Vinci systems in the quarter, up from 96 a year earlier. The United States and Japan accounted for most of the growth in system sales, Chief Executive Gary Guthart said.Surgical procedures using the company's systems increased about 10 percent in the United States and 27 percent elsewhere, company executives said on a media call. Intuitive also earns each time one of its systems is used in surgery. Guthart also said the company's gross margins were moving in the right direction as it cut product costs.Intuitive's pro forma gross margins rose to 68 percent in the second quarter from 65.6 percent in the first quarter.Revenue from the company's instrument and accessory business, its largest, rose about 13 percent to $297 million. Net income rose to $134.5 million, or $3.56 per share, in the second quarter ended June 30, from $104 million, or $2.77 per share, a year earlier.On an adjusted basis, Intuitive earned $4.57 per share, well above the average analyst estimate of $3.98, according to Thomson Reuters I/B/E/S.Revenue rose 14 percent to $586 million, beating the average estimate of $566.9 million.Up to Tuesday's close of $505.09, Intuitive's shares had fallen about 4.5 percent this year. The stock was up nearly 12 percent at $565 in after-market trading.   (Reporting by Anjali Rao Koppala and Amrutha Penumudi in Bengaluru; Editing by Maju Samuel)",2015-07-21,ISRG,"Tue Jul 21, 2015 | 6:20pm EDT","UPDATE 2-Intuitive Surgical serves up strong quarter, shares jump 13 pct",http://www.reuters.com//article/intuitive-results-idUSL3N1015HE20150721?type=companyNews
27,"  July 21 Robotic surgical equipment maker Intuitive Surgical Inc posted a 30 percent jump in quarterly profit, helped by a rise in procedures in most of its markets.The company's net income rose to $134.5 million, or $3.56 per share, in the second quarter ended June 30, from $104 million, or $2.77 per share, a year earlier. On an adjusted basis, it earned $4.57 per share.  Revenue rose about 16 percent to $586 million.   (Reporting by Amrutha Penumudi in Bengaluru; Editing by Maju Samuel)",2015-07-21,ISRG,"Tue Jul 21, 2015 | 4:18pm EDT",Intuitive Surgical posts 30 pct rise in profit,http://www.reuters.com//article/intuitive-results-idUSL3N1015FA20150721?type=companyNews
28,  Aug 4 Intuitive Aerial publ AB :* Says Welk Aviation buys two AERIGON systems with the first FAA approval in Hollywood  Source text for Eikon:  Further company coverage:    (Gdynia Newsroom) ,2015-08-04,ISRG,"Tue Aug 4, 2015 | 7:28am EDT",BRIEF-Welk Aviation orders two AERIGON systems of Intuitive Aerial AB,http://www.reuters.com//article/idUSFWN10F00U20150804?type=companyNews
29,"  Aug 27 Intuitive Aerial publ AB :* H1 net sales 878,479 Swedish crowns  ($104,000) * H1 operating loss 6.5 million crowns Source text for Eikon: Further company coverage:   ($1 = 8.4628 Swedish crowns)   (Gdynia Newsroom)",2015-08-27,ISRG,"Thu Aug 27, 2015 | 2:38am EDT",BRIEF-Intuitive Aerial H1 operating loss SEK 6.5 million,http://www.reuters.com//article/idUSFWN11203G20150827?type=companyNews
30,"  (Adds details, share movement)Oct 20 Intuitive Surgical Inc, which makes robotic equipment to help in surgeries, reported better-than-expected quarterly profit and revenue, helped by a lower tax rate and increasing use of its flagship da Vinci system in surgeries.The company's shares rose more than 7 percent after market.Intuitive Surgical's net income rose to $167.3 million, or $4.40 per share, in the third quarter ended Sept. 30, from $123.7 million, or $3.35 per share, a year earlier. The company reported non-GAAP earnings of $5.24 per share and said its tax rate dropped to 18 percent from 27 percent.Excluding a tax benefit, the company earned $4.47 per share, which topped analysts average estimate of $4.23, according to Thomson Reuters I/B/E/S. Revenue, excluding items, rose 7 percent to $589.7 million, beating analysts expectations of $580.4 million. Intuitive Surgical's flagship da Vinci system assists in minimally invasive gynecological and urological surgeries.The company said it shipped 117 da Vinci systems in the third quarter, one less than it shipped in the second quarter and six more than the year-ago quarter.However a 15 percent rise worldwide in procedures using the da Vinci system helped boost revenue.   (Reporting by Samantha Kareen Nair and Natalie Grover in Bengaluru; Editing by Savio D'Souza)",2015-10-20,ISRG,"Tue Oct 20, 2015 | 4:56pm EDT",UPDATE 1-Intuitive Surgical Q3 revenue beats estimates,http://www.reuters.com//article/intuitive-results-idUSL3N12K5BS20151020?type=companyNews
31,"  Oct 20 Robotic surgical equipment maker Intuitive Surgical reported a 7 percent rise in quarterly adjusted revenue, driven mainly by an increase in general surgeries in the United States.The company's net income rose to $167.3 million, or $4.40 per share, in the third quarter ended Sept. 30, from $123.7 million, or $3.35 per share, a year earlier.  Revenue, excluding items, rose to $589.7 million from $550.1 million.   (Reporting by Samantha Kareen Nair in Bengaluru; Editing by Savio D'Souza) ",2015-10-20,ISRG,"Tue Oct 20, 2015 | 4:19pm EDT",Intuitive revenue rises 7 pct due to more U.S. surgeries,http://www.reuters.com//article/intuitive-results-idUSL3N12K5AL20151020?type=companyNews
32,"   By Lewis Krauskopf | NEW YORK  NEW YORK In a beaten-up stock market, Intuitive Surgical Inc (ISRG.O) stands out as the best-performing large-cap U.S. healthcare stock that is not an acquisition target.Shares of Intuitive, which boasts a dominant position in surgical robotic systems, have climbed 13 percent over six months. Over the same period, the Standard & Poor's healthcare sector index .SPXHC has slid 13 percent, and the only stock in the index to top Intuitive's performance was Baxalta Inc BXLT.N, which recently agreed to be acquired for $32 billion by Shire Plc (SHP.L) [nL8N14V2FI]. Intuitive's signature product, the $1.5 million da Vinci robotic system used in gynecological and prostate surgeries, has been used in more procedures and the company has seen improving profit margins, said RBC Capital Markets analyst Brandon Henry.""Theyre kind of clicking on all cylinders"" in recent quarters, he said. A test for the stock's momentum could come after the market closes on Thursday, when the $20 billion market-cap company reports fourth-quarter results. The Sunnyvale, California, company has already announced that it expects a 12 percent increase in fourth-quarter revenue, which topped analysts' views, and expects procedures using the da Vinci system to rise about 9 percent to 12 percent in 2016. It was unclear whether investors will find more to like in Thursday's report, or sell on confirmation of the pre-report. Pricing in the options market on Wednesday suggested a move of 6.3 percent in either direction by Friday. With the S&P healthcare index down 7 percent on the year, Intuitive Surgical is one of only a few in the index in positive territory for 2016. Intuitive's dominance in its market appealed to Baltimore investment counselor D.F. Dent & Co, which owned about 170,000 shares as of the latest filing data.""If you run a hospital and want to buy a surgical robot, Intuitive Surgical is basically the only option you have,"" said Gary Wu, vice president at D.F. Dent. Wu said D.F. Dent was neither adding to or reducing its position. He said some investors could be reluctant to purchase Intuitive shares because of its valuation.At $556 a share, the stock is trading at about 27 times forward 12 months earnings estimates, nearly double the 15 times for the broader S&P 500 index .SPX. Still, a pricey multiple is not unusual for the company, with its current P/E ratio below the 35 times the stock has traded at on average over the past decade.Looming competition could sway the stock going forward. Large medical device companies, such as Johnson & Johnson (JNJ.N) and Medtronic (MDT.N), are developing competing robotics products as are smaller firms such as Titan Medical Inc (TMD.TO) and TransEnterix TRCX.A.""Intuitive has been the only game in town for the last 10 years,"" said Greg Chodaczek, an analyst at Sterne Agee CRT. In Medtronic and J&J, ""you have two formidable competitors on the horizon.""On Thursday, the company is expected to provide a more complete picture of its results, including its quarterly earnings and margins.""The stock has had a decent move, so if they dont say anything new, do folks take some of the profits and wait until next quarter? Maybe,"" said Tao Levy, an analyst at Wedbush Securities, who is bullish on the prospect for adoption of robotic procedures and rates the stock ""outperform."" (Reporting by Lewis Krauskopf, additional reporting by Saqib Iqbal Ahmed; Editing by David Gregorio; editing by Linda Stern and David Gregorio)",2016-01-20,ISRG,"Wed Jan 20, 2016 | 5:00pm EST",Intuitive Surgical stock run leads healthcare group as Q4 report nears,http://www.reuters.com//article/intuitive-stocks-idUSL2N1540VL?type=companyNews
33,"   By Bill Berkrot  Intuitive Surgical Inc (ISRG.O) on Thursday reported fourth-quarter profit that sailed past Wall Street estimates as it sold more da Vinci surgical robots and saw a big increase in international procedures using the high-priced systems.However, the company cautioned that first quarter sales were likely to be lower than the just-reported quarter, and said it expects business outside the United States to be uneven this year for a variety of reasons, including markets constrained by government regulations. Excluding one-time items, Intuitive said it earned $5.89 per share, topping analysts' average expectations by 85 cents, according to Thomson Reuters I/B/E/S.Despite preannouncing some results last week, ""Intuitive Surgical still managed to surprise us on the upside with a massive EPS beat driven by gross margin improvements and impressive operating leverage,"" Evercore ISI analyst Vijay Kumar said in a research note.Gross margin improvement was helped by suspension of the medical device tax. Net profit for the quarter rose to $190 million, or $4.99 per share, from $147 million, or $3.94 per share, in the year-ago period.The quarterly results were buoyed by expanded use of its robots for general surgery procedures such as hernia repair, that helped offset slow growth in gynecological business, and a 27 percent jump in international procedures.Average revenue per procedure was $1,840, the company said. The company said last week it expects procedures using da Vinci robots to increase 9 percent to 12 percent in 2016.Intuitive also previously reported fourth-quarter revenue of $677 million, and said it sold 158 da Vinci systems at an average cost of about $1.5 million, up from 137 units sold in the year-ago quarter and 117 in the prior quarter. The company said on a conference call with analysts and investors that it does not expect the impact of foreign exchange to be as pronounced this year as it was in 2015, when the strength of the dollar hurt overseas sales.Intuitive said U.S. health regulators have cleared use of the company's movable surgical table to be used in conjunction with the da Vinci system, which allows for repositioning of the patient to better assist in robotic surgical procedures.Intuitive shares were up nearly 1 percent at $559.90 in extended trading from their Nasdaq close at $555.60. (Reporting by Bill Berkrot; Editing by Cynthia Osterman and Tom Brown)",2016-01-21,ISRG,"Thu Jan 21, 2016 | 6:09pm EST",Intuitive Surgical fourth-quarter profit tops expectations,http://www.reuters.com//article/us-intuitive-results-idUSKCN0UZ2UJ?type=companyNews
34,"   By Bill Berkrot  Intuitive Surgical Inc (ISRG.O) on Thursday reported fourth-quarter profit that sailed past Wall Street estimates as it sold more da Vinci surgical robots and saw a big increase in international procedures using the high-priced systems.However, the company cautioned that first quarter sales were likely to be lower than the just-reported quarter, and said it expects business outside the United States to be uneven this year for a variety of reasons, including markets constrained by government regulations. Excluding one-time items, Intuitive said it earned $5.89 per share, topping analysts' average expectations by 85 cents, according to Thomson Reuters I/B/E/S.Despite preannouncing some results last week, ""Intuitive Surgical still managed to surprise us on the upside with a massive EPS beat driven by gross margin improvements and impressive operating leverage,"" Evercore ISI analyst Vijay Kumar said in a research note.Gross margin improvement was helped by suspension of the medical device tax. Net profit for the quarter rose to $190 million, or $4.99 per share, from $147 million, or $3.94 per share, in the year-ago period.The quarterly results were buoyed by expanded use of its robots for general surgery procedures such as hernia repair, that helped offset slow growth in gynecological business, and a 27 percent jump in international procedures.Average revenue per procedure was $1,840, the company said. The company said last week it expects procedures using da Vinci robots to increase 9 percent to 12 percent in 2016.Intuitive also previously reported fourth-quarter revenue of $677 million, and said it sold 158 da Vinci systems at an average cost of about $1.5 million, up from 137 units sold in the year-ago quarter and 117 in the prior quarter. The company said on a conference call with analysts and investors that it does not expect the impact of foreign exchange to be as pronounced this year as it was in 2015, when the strength of the dollar hurt overseas sales.Intuitive said U.S. health regulators have cleared use of the company's movable surgical table to be used in conjunction with the da Vinci system, which allows for repositioning of the patient to better assist in robotic surgical procedures.Intuitive shares were up nearly 1 percent at $559.90 in extended trading from their Nasdaq close at $555.60. (Reporting by Bill Berkrot; Editing by Cynthia Osterman and Tom Brown)",2016-01-21,ISRG,"Thu Jan 21, 2016 | 6:09pm EST",UPDATE 2-Intuitive Surgical 4th-quarter profit tops expectations,http://www.reuters.com//article/intuitive-results-idUSL2N1552UJ?type=companyNews
35,  Jan 21 Intuitive Surgical Inc* Sees q1 sales lower than just reported q4 2015  * Intuitive Surgical sees 2016 tax rate 26.5 percent to 28.5 percent of pre tax income  Source text for Eikon:  Further company coverage:    (Reporting By Bill Berkrot) ,2016-01-21,ISRG,"Thu Jan 21, 2016 | 5:33pm EST",BRIEF-Intuitive Surgical sees 1st quarter sales below '15 4th quarter,http://www.reuters.com//article/idUSL2N155301?type=companyNews
36,"  Jan 21 Intuitive Surgical Inc on Thursday reported higher-than-expected fourth-quarter profit on increased sales of its high-priced da Vinci surgical robots.Net profit rose to $190 million, or $4.99 per share, from $147 million, or $3.94 per share, in the year-ago period. Excluding one-time items, Intuitive said it earned $5.89 per share. Analysts on average had expected $5.04 per share, according to Thomson Reuters I/B/E/S. The company said last week it expected procedures using da Vinci robots to increase 9 percent to 12 percent in 2016. Intuitive also previously reported fourth-quarter revenue of $677 million and said it sold 158 da Vinci systems, up from 137 in the year-ago quarter and 117 in the prior quarter.   (Reporting by Bill Berkrot; Editing by Richard Chang)",2016-01-21,ISRG,"Thu Jan 21, 2016 | 4:20pm EST",Intuitive Surgical 4th-quarter profit tops expectations,http://www.reuters.com//article/intuitive-results-idUSL2N1542RI?type=companyNews
37,"  (Repeats story published on Jan 20, no changes)By Lewis KrauskopfNEW YORK Jan 20 In a beaten-up stock market, Intuitive Surgical Inc stands out as the best-performing large-cap U.S. healthcare stock that is not an acquisition target.Shares of Intuitive, which boasts a dominant position in surgical robotic systems, have climbed 13 percent over six months. Over the same period, the Standard & Poor's healthcare sector index has slid 13 percent, and the only stock in the index to top Intuitive's performance was Baxalta Inc , which recently agreed to be acquired for $32 billion by Shire Plc.Intuitive's signature product, the $1.5 million da Vinci robotic system used in gynecological and prostate surgeries, has been used in more procedures and the company has seen improving profit margins, said RBC Capital Markets analyst Brandon Henry.""They're kind of clicking on all cylinders"" in recent quarters, he said.A test for the stock's momentum could come after the market closes on Thursday, when the $20 billion market-cap company reports fourth-quarter results. The Sunnyvale, California, company has already announced that it expects a 12 percent increase in fourth-quarter revenue, which topped analysts' views, and expects procedures using the da Vinci system to rise about 9 percent to 12 percent in 2016. It was unclear whether investors will find more to like in Thursday's report, or sell on confirmation of the pre-report. Pricing in the options market on Wednesday suggested a move of 6.3 percent in either direction by Friday.With the S&P healthcare index down 7 percent on the year, Intuitive Surgical is one of only a few in the index in positive territory for 2016.Intuitive's dominance in its market appealed to Baltimore investment counselor D.F. Dent & Co, which owned about 170,000 shares as of the latest filing data. ""If you run a hospital and want to buy a surgical robot, Intuitive Surgical is basically the only option you have,"" said Gary Wu, vice president at D.F. Dent.Wu said D.F. Dent was neither adding to or reducing its position. He said some investors could be reluctant to purchase Intuitive shares because of its valuation.At $556 a share, the stock is trading at about 27 times forward 12 months earnings estimates, nearly double the 15 times for the broader S&P 500 index. Still, a pricey multiple is not unusual for the company, with its current P/E ratio below the 35 times the stock has traded at on average over the past decade. Looming competition could sway the stock going forward.Large medical device companies, such as Johnson & Johnson  and Medtronic, are developing competing robotics products as are smaller firms such as Titan Medical Inc  and TransEnterix.""Intuitive has been the only game in town for the last 10 years,"" said Greg Chodaczek, an analyst at Sterne Agee CRT. In Medtronic and J&J, ""you have two formidable competitors on the horizon.""On Thursday, the company is expected to provide a more complete picture of its results, including its quarterly earnings and margins.""The stock has had a decent move, so if they don't say anything new, do folks take some of the profits and wait until next quarter? Maybe,"" said Tao Levy, an analyst at Wedbush Securities, who is bullish on the prospect for adoption of robotic procedures and rates the stock ""outperform.""   (Reporting by Lewis Krauskopf, additional reporting by Saqib Iqbal Ahmed; Editing by David Gregorio; editing by Linda Stern and David Gregorio)",2016-01-21,ISRG,"Thu Jan 21, 2016 | 7:00am EST",RPT--Intuitive Surgical stock run leads healthcare group as Q4 report nears,http://www.reuters.com//article/intuitive-stocks-idUSL2N1542K5?type=companyNews
38,"  Feb 25 Intuitive Aerial publ AB :* FY net sales 4.8 million Swedish crowns ($565,870.91) versus 5.1 million crowns year ago * FY operating loss 12.1 million crowns versus loss 4.2 million crowns year ago  Source text for Eikon:  Further company coverage:   ($1 = 8.4825 Swedish crowns)   (Gdynia Newsroom)",2016-02-25,ISRG,"Thu Feb 25, 2016 | 2:57am EST",BRIEF-Intuitive Aerial 2015 operating loss widens to SEK 12.1 million,http://www.reuters.com//article/idUSFWN164010?type=companyNews
39,  April 19 Intuitive Surgical Inc :* Q1 non-GAAP earnings per share $4.42* Q1 revenue $595 million versus i/b/e/s view $593.1 million * Intuitive surgical announces first quarter earnings * Q1 GAAP earnings per share $3.54 * Q1 earnings per share view $4.33 -- Thomson Reuters I/B/E/S  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom: +1-646-223-8780),2016-04-19,ISRG,"Tue Apr 19, 2016 | 4:36pm EDT",BRIEF-Intuitive Surgical Q1 non-GAAP earnings per share $4.42,http://www.reuters.com//article/idUSASD08E5R?type=companyNews
40,"  April 19 Intuitive Surgical Inc on Tuesday reported a first-quarter profit that topped Wall Street expectations, helped by expanded use of its da Vinci surgical robots in U.S. general surgery procedures.Excluding one-time items, Intuitive said it earned $4.42 a share. Analysts on average expected $4.33 a share, according to Thomson Reuters I/B/E/S. Net profit for the quarter rose to $136 million, or $3.54 a share, from $97 million, or $2.57 a share, a year ago. Revenue rose 12 percent to $595 million.  (Reporting by Susan Kelly in Chicago; Editing by Leslie Adler)",2016-04-19,ISRG,"Tue Apr 19, 2016 | 4:18pm EDT",Intuitive Surgical first-quarter profit beats expectations,http://www.reuters.com//article/intuitivesurgical-results-idUSL2N17L21G?type=companyNews
41,"  Intuitive Surgical Inc on Tuesday reported much higher than expected second-quarter profit, driven by an increase in sales of its da Vinci surgical robots and in procedures using the pricey machines, and its shares rose more than 5 percent.The company during the quarter shipped 130 da Vinci systems, which sell for about $1.5 million each, up from 110 in the prior quarter and 118 a year ago.It said instrument and accessory revenue rose 14 percent as procedures using da Vincis climbed 16 percent, driving by growth in U.S. general surgeries and urological procedures, such as prostate surgeries, outside the United States.  Intuitive said net profit rose to $185 million, or $4.71 per share, from $135 million, or $3.56 per share, a year ago. Excluding one-time items, Intuitive said it earned $5.62 per share. Analysts on average expected $4.97 per share, according to Thomson Reuters I/B/E/S.  Overall revenue for the quarter rose about 14 percent to $670 million, topping Wall Street estimates of $640.7 million. Intuitive shares rose to $709 in extended trading from a Nasdaq close at $671.90. Intuitive shares are up nearly 20 percent since the beginning of 2016.   (Reporting by Bill Berkrot in New York; Editing by Matthew Lewis)",2016-07-19,ISRG,"Tue Jul 19, 2016 | 4:38pm EDT","UPDATE 2-Intuitive Surgical 2nd-quarter profit jumps, shares rise",http://www.reuters.com//article/intuitive-results-idUSL1N1A51MU?type=companyNews
42,"  July 19 Intuitive Surgical Inc* Sees full year procedure growth of 14-15 percent, up from prior forecast of 12-14 percent  * 71 percent of net revs, up from prior view 69-70 percent  Source text for Eikon:  Further company coverage:    (Reporting By Bill Berkrot) ",2016-07-19,ISRG,"Tue Jul 19, 2016 | 5:13pm EDT",BRIEF-Intuitive Surgical raises 2016 prodecure growth forecast,http://www.reuters.com//article/idUSL1N1A51QH?type=companyNews
43,  July 19 Intuitive Surgical Inc* Intuitive Surgical announces second quarter earnings* Q2 Non-GAAP earnings per share $5.62 * Q2 GAAP earnings per share $4.71 * Q2 revenue $670 million versus i/b/e/s view $640.7 million * Q2 earnings per share view $4.97 -- Thomson Reuters I/B/E/S* Company shipped 130 Da Vinci Surgical Systems in Q2 compared with 118 in Q2 of 2015  Source text for Eikon:  Further company coverage:,2016-07-19,ISRG,"Tue Jul 19, 2016 | 4:38pm EDT",BRIEF-Intuitive Surgical reports Q2 GAAP EPS $4.71,http://www.reuters.com//article/idUSASC08XCC?type=companyNews
44,"  Intuitive Surgical Inc on Tuesday reported much higher than expected second-quarter profit, driven by an increase in sales of its da Vinci surgical robots and in procedures using the pricey machines, and its shares rose more than 5 percent.The company during the quarter shipped 130 da Vinci systems, which sell for about $1.5 million each, up from 110 in the prior quarter and 118 a year ago.It said instrument and accessory revenue rose 14 percent as procedures using da Vincis climbed 16 percent, driving by growth in U.S. general surgeries and urological procedures, such as prostate surgeries, outside the United States.  Intuitive said net profit rose to $185 million, or $4.71 per share, from $135 million, or $3.56 per share, a year ago. Excluding one-time items, Intuitive said it earned $5.62 per share. Analysts on average expected $4.97 per share, according to Thomson Reuters I/B/E/S.  Overall revenue for the quarter rose about 14 percent to $670 million, topping Wall Street estimates of $640.7 million. Intuitive shares rose to $709 in extended trading from a Nasdaq close at $671.90. Intuitive shares are up nearly 20 percent since the beginning of 2016.   (Reporting by Bill Berkrot in New York; Editing by Matthew Lewis)",2016-07-19,ISRG,"Tue Jul 19, 2016 | 4:38pm EDT",Intuitive Surgical second-quarter profit jumps past expectations,http://www.reuters.com//article/us-intuitive-results-idUSKCN0ZZ2O0?type=companyNews
45,"  July 19 Intuitive Surgical Inc on Tuesday reported higher second-quarter profit, driven by an increase in sales of its da Vinci surgical robots and in procedures using the pricey machines.Intuitive said net profit rose to $185 million, or $4.71 per share, from $135 million, or $3.56 per share, a year ago. Excluding one-time items, Intuitive said it earned $5.62 per share.  Revenue for the quarter rose about 14 percent to $670 million, topping Wall Street estimates of $640.7 million, according to Thomson Reuters I/B/E/S.    (Reporting by Bill Berkrot in New York; Editing by Matthew Lewis)",2016-07-19,ISRG,"Tue Jul 19, 2016 | 4:16pm EDT",Intuitive Surgical second-quarter profit jumps,http://www.reuters.com//article/intuitive-results-idUSL1N1A51MM?type=companyNews
46,"   By Susan Kelly | CHICAGO  CHICAGO Even though many doctors see need for improvement, surgical robots are poised for big gains in operating rooms around the world.Within five years, one in three U.S. surgeries - more than double current levels  is expected to be performed with robotic systems, with surgeons sitting at computer consoles guiding mechanical arms. Companies developing new robots also plan to expand their use in India, China and other emerging markets.Robotic surgery has been long dominated by pioneer Intuitive Surgical Inc, which has more than 3,600 of its da Vinci machines in hospitals worldwide and said last week the number of procedures that used them jumped by 16 percent in the second quarter compared to a year earlier.The anticipated future growth - and perceived weaknesses of the current generation of robots - is attracting deep-pocketed rivals, including Medtronic Inc and a startup backed by Johnson & Johnson and Google. Developers of the next wave aim to make the robots less expensive, more nimble and capable of performing more types of procedures, company executives and surgeons told Reuters.Although surgical robots run an average of $1.5 million and entail ongoing maintenance expenses, insurers pay no more for surgeries that utilize the systems than for other types of minimally-invasive procedures, such as laparoscopy.  Still, most top U.S. hospitals for cancer treatment, urology, gynecology and gastroenterology have made the investment. The robots are featured prominently in hospital marketing campaigns aimed at attracting patients, and new doctors are routinely trained in their use.Surgical robots are used in hernia repair, bariatric surgery, hysterectomies and the vast majority of prostate removals in the United States, according to Intuitive Surgical data.Doctors say they reduce fatigue and give them greater precision.But robot-assisted surgery can take more of the surgeon's time than traditional procedures, reducing the number of operations doctors can perform. That's turned off some like Dr. Helmuth Billy.  Billy was an early adopter of Intuitive's da Vinci system 15 years ago. But equipping its arms with instruments slowed him down. He rarely uses it now.""I like to do five operations a day,"" Billy said. ""If I have to constantly dock and undock da Vinci, it becomes cumbersome.""     SURGEONS' WISH LIST To gain an edge, new robots will need to outperform laparoscopic surgery, said Dr. Dmitry Oleynikov, who heads a robotics task force for the Society of American Gastrointestinal and Endoscopic Surgeons. Surgeons told Reuters they want robots to provide a way to feel the body's tissue remotely, called haptic sensing, and better camera image quality.New systems also will need to be priced low enough to entice hospitals and outpatient surgical centers that have not yet invested in a da Vinci, as well as convince those with established robotic programs to consider a second vendor or switching suppliers altogether.""That is where competitors can differentiate,"" said Vik Srinivasan of the Advisory Board Co, a research and consulting firm that advises hospitals.Developers say they are paying attention. Verb Surgical, the J&J-Google venture that is investing about $250 million in its project, said creating a faster and easier-to-use system is a priority.  Verb also envisions a system that is ""always there, always on,"" enabling the surgeon to use the robot for parts of a procedure as needed, said Chief Executive Scott Huennekens.Intuitive said it too is looking to improve technology at a reasonable cost, but newcomers will face the same challenges.""As competitors come in, they are going to have to work within that same framework,"" CEO Gary Guthart said in an interview.Device maker Medtronic has said it expects to launch its surgical robot before mid-2018 and will start in India. Others developing surgical robots include TransEnterix Inc and Canada's Titan Medical Inc.An RBC Capital Markets survey found that U.S. surgeons expect about 35 percent of operations will involve robots in five years, up from 15 percent today. J&J, which hopes to be second to market with a product from Verb, has said it sees robotics as a multibillion-dollar market opportunity. Huennekens said Verb's surgical robot will differ from another Google robotics effort, the driverless car, in one important aspect.""There will always be a surgeon there,"" he said. (Reporting by Susan Kelly; Editing by Michele Gershberg and Lisa Girion)",2016-07-28,ISRG,"Thu Jul 28, 2016 | 1:29am EDT",New crop of robots to vie for space in the operating room,http://www.reuters.com//article/us-health-robots-idUSKCN1080CK?type=companyNews
47,"   By Susan Kelly | CHICAGO  CHICAGO Even though many doctors see need for improvement, surgical robots are poised for big gains in operating rooms around the world.Within five years, one in three U.S. surgeries - more than double current levels  is expected to be performed with robotic systems, with surgeons sitting at computer consoles guiding mechanical arms. Companies developing new robots also plan to expand their use in India, China and other emerging markets.Robotic surgery has been long dominated by pioneer Intuitive Surgical Inc, which has more than 3,600 of its da Vinci machines in hospitals worldwide and said last week the number of procedures that used them jumped by 16 percent in the second quarter compared to a year earlier.The anticipated future growth - and perceived weaknesses of the current generation of robots - is attracting deep-pocketed rivals, including Medtronic Inc and a startup backed by Johnson & Johnson and Google. Developers of the next wave aim to make the robots less expensive, more nimble and capable of performing more types of procedures, company executives and surgeons told Reuters.Although surgical robots run an average of $1.5 million and entail ongoing maintenance expenses, insurers pay no more for surgeries that utilize the systems than for other types of minimally-invasive procedures, such as laparoscopy.  Still, most top U.S. hospitals for cancer treatment, urology, gynecology and gastroenterology have made the investment. The robots are featured prominently in hospital marketing campaigns aimed at attracting patients, and new doctors are routinely trained in their use.Surgical robots are used in hernia repair, bariatric surgery, hysterectomies and the vast majority of prostate removals in the United States, according to Intuitive Surgical data.Doctors say they reduce fatigue and give them greater precision.But robot-assisted surgery can take more of the surgeon's time than traditional procedures, reducing the number of operations doctors can perform. That's turned off some like Dr. Helmuth Billy.  Billy was an early adopter of Intuitive's da Vinci system 15 years ago. But equipping its arms with instruments slowed him down. He rarely uses it now.""I like to do five operations a day,"" Billy said. ""If I have to constantly dock and undock da Vinci, it becomes cumbersome.""     SURGEONS' WISH LIST To gain an edge, new robots will need to outperform laparoscopic surgery, said Dr. Dmitry Oleynikov, who heads a robotics task force for the Society of American Gastrointestinal and Endoscopic Surgeons. Surgeons told Reuters they want robots to provide a way to feel the body's tissue remotely, called haptic sensing, and better camera image quality.New systems also will need to be priced low enough to entice hospitals and outpatient surgical centers that have not yet invested in a da Vinci, as well as convince those with established robotic programs to consider a second vendor or switching suppliers altogether.""That is where competitors can differentiate,"" said Vik Srinivasan of the Advisory Board Co, a research and consulting firm that advises hospitals.Developers say they are paying attention. Verb Surgical, the J&J-Google venture that is investing about $250 million in its project, said creating a faster and easier-to-use system is a priority.  Verb also envisions a system that is ""always there, always on,"" enabling the surgeon to use the robot for parts of a procedure as needed, said Chief Executive Scott Huennekens.Intuitive said it too is looking to improve technology at a reasonable cost, but newcomers will face the same challenges.""As competitors come in, they are going to have to work within that same framework,"" CEO Gary Guthart said in an interview.Device maker Medtronic has said it expects to launch its surgical robot before mid-2018 and will start in India. Others developing surgical robots include TransEnterix Inc and Canada's Titan Medical Inc.An RBC Capital Markets survey found that U.S. surgeons expect about 35 percent of operations will involve robots in five years, up from 15 percent today. J&J, which hopes to be second to market with a product from Verb, has said it sees robotics as a multibillion-dollar market opportunity. Huennekens said Verb's surgical robot will differ from another Google robotics effort, the driverless car, in one important aspect.""There will always be a surgeon there,"" he said. (Reporting by Susan Kelly; Editing by Michele Gershberg and Lisa Girion)",2016-07-28,ISRG,"Thu Jul 28, 2016 | 1:29am EDT",New crop of robots to vie for space in the operating room,http://www.reuters.com//article/health-robots-idUSL1N1AB1KP?type=companyNews
48,"  Sept 29 Intuitive Surgical Inc* Companies will contribute up to $100 million as required by joint venture* Joint venture will be registered in Shanghai * Distribution in China will be conducted by joint venture * Intuitive Surgical and Fosun Pharma establish joint venture to research, develop, manufacture  and sell lung cancer diagnostic and therapeutic tools in China * Distribution outside of China will be conducted by Intuitive Surgical  Source text for Eikon:  Further company coverage:",2016-09-29,ISRG,"Thu Sep 29, 2016 | 9:20am EDT",BRIEF-Intuitive Surgical & Fosun Pharma establish joint venture,http://www.reuters.com//article/idUSFWN1C50D7?type=companyNews
49,"   By Bill Berkrot  Intuitive Surgical Inc (ISRG.O) on Tuesday reported a 26 percent increase in third-quarter profit on higher sales of its da Vinci surgical robots and double-digit growth in procedures using the pricey equipment.However, the company maintained its full-year forecast for procedure growth of 14 percent to 15 percent, and its shares fell.The Sunnyvale, California-based company said it sold 134 da Vinci systems in the quarter, up from 117 a year ago and 130 shipped in the previous quarter, at a cost of about $1.5 million each.Procedures using da Vinci systems grew about 14 percent, driven primarily by general surgery in the United States, such as hernia repairs and colorectal surgeries, and by prostate  procedures outside the United States.  On a conference call with analysts, Intuitive said it reaped about $1,870 per procedure, up from both a year ago and the prior quarter. It said procedures grew by 25 percent outside the United States, with uneven growth in Europe and continued strength in China and South Korea.Intuitive posted a net profit of $211 million, or $5.31 per share, compared with a profit of $167.3 million, or $4.40, a year ago.Excluding items, Intuitive said it earned $6.19 per share, helped by a 77 cent tax gain. Analysts on average expected $5.14  per share, according to Thomson Reuters I/B/E/S.     Overall revenue for the quarter rose about 16 percent to $683 million, topping analyst expectations for sales of $650.5 million. Instrument and accessory revenue rose by about 17 percent to $348 million, while service revenue increased about 10 percent to $130 million.""Intuitive Surgical reported an impressive revenue and a massive EPS beat,"" Evercore ISI analyst Vijay Kumar said in a research note, adding that the results were driven by higher-than-expected da Vinci system placements.            The company said it has added 400 employees year to date and sees operating expense growth accelerating. For the quarter, operating expenses rose to $230.6 million from $205.9 million a year ago.Intuitive shares slipped 1.6 percent to $710 in extended trading. Its share price is still up about 30 percent for the year. (Reporting by Bill Berkrot in New York; editing by Will Dunham and Alan Crosby)",2016-10-18,ISRG,"Tue Oct 18, 2016 | 6:49pm EDT",Intuitive Surgical profit jumps; maintains growth forecast,http://www.reuters.com//article/us-intuitive-results-idUSKCN12I2LN?type=companyNews
50,"   By Bill Berkrot  Intuitive Surgical Inc (ISRG.O) on Tuesday reported a 26 percent increase in third-quarter profit on higher sales of its da Vinci surgical robots and double-digit growth in procedures using the pricey equipment.However, the company maintained its full-year forecast for procedure growth of 14 percent to 15 percent, and its shares fell.The Sunnyvale, California-based company said it sold 134 da Vinci systems in the quarter, up from 117 a year ago and 130 shipped in the previous quarter, at a cost of about $1.5 million each.Procedures using da Vinci systems grew about 14 percent, driven primarily by general surgery in the United States, such as hernia repairs and colorectal surgeries, and by prostate  procedures outside the United States.  On a conference call with analysts, Intuitive said it reaped about $1,870 per procedure, up from both a year ago and the prior quarter. It said procedures grew by 25 percent outside the United States, with uneven growth in Europe and continued strength in China and South Korea.Intuitive posted a net profit of $211 million, or $5.31 per share, compared with a profit of $167.3 million, or $4.40, a year ago.Excluding items, Intuitive said it earned $6.19 per share, helped by a 77 cent tax gain. Analysts on average expected $5.14  per share, according to Thomson Reuters I/B/E/S.     Overall revenue for the quarter rose about 16 percent to $683 million, topping analyst expectations for sales of $650.5 million. Instrument and accessory revenue rose by about 17 percent to $348 million, while service revenue increased about 10 percent to $130 million.""Intuitive Surgical reported an impressive revenue and a massive EPS beat,"" Evercore ISI analyst Vijay Kumar said in a research note, adding that the results were driven by higher-than-expected da Vinci system placements.            The company said it has added 400 employees year to date and sees operating expense growth accelerating. For the quarter, operating expenses rose to $230.6 million from $205.9 million a year ago.Intuitive shares slipped 1.6 percent to $710 in extended trading. Its share price is still up about 30 percent for the year. (Reporting by Bill Berkrot in New York; editing by Will Dunham and Alan Crosby)",2016-10-18,ISRG,"Tue Oct 18, 2016 | 6:49pm EDT",UPDATE 2-Intuitive Surgical profit jumps; maintains growth forecast,http://www.reuters.com//article/intuitive-results-idUSL1N1CO1W7?type=companyNews
51,"  Oct 18 Intuitive Surgical Inc on Tuesday reported higher third-quarter profit on increased sales of its da Vinci surgical robots and double-digit growth in procedures using the pricey equipment.The company posted a net profit of $211 million, or $5.31 per share, compared with a profit of $167.3 million, or $4.40, a year ago. Excluding items, Intuitive said it earned $6.19 per share, helped by a 77 cent tax gain. Analysts on average expected $5.14  per share, according to Thomson Reuters I/B/E/S.  Revenue for the quarter rose about 16 percent to $683 million, topping analyst expectations for sales of $650.5 million.    (Reporting by Bill Berkrot in New York; Editing by Matthew Lewis)",2016-10-18,ISRG,"Tue Oct 18, 2016 | 4:21pm EDT",Intuitive Surgical third-quarter profit jumps,http://www.reuters.com//article/intuitive-results-idUSL1N1CN1UP?type=companyNews
52,  Oct 18 Intuitive Surgical Inc* Q3 non-GAAP earnings per share $6.19* Q3 GAAP earnings per share $5.31 * Q3 revenue $683 million versus I/B/E/S view $650.5 million * Q3 earnings per share view $5.14 -- Thomson Reuters I/B/E/S * Says shipped 134 da vinci surgical systems in Q3 compared with 117 in Q3 of 2015  Source text for Eikon:  Further company coverage:,2016-10-18,ISRG,"Tue Oct 18, 2016 | 4:19pm EDT",BRIEF-Intuitive Surgical Q3 GAAP earnings per share $5.31,http://www.reuters.com//article/idUSASC09BNG?type=companyNews
53,"  Nov 28 Intuitive Aerial publ AB :* Receives order and signs supplier contract with BBC * Order amounts to about 50,000 euros ($53,305) Source text for Eikon: Further company coverage:   ($1 = 0.9380 euros)   (Gdynia Newsroom)",2016-11-28,ISRG,"Mon Nov 28, 2016 | 2:56am EST",BRIEF-Intuitive Aerial gets order and signs supplier contract with BBC,http://www.reuters.com//article/idUSFWN1DT08R?type=companyNews
